Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taylor Morrisette

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
Pharmacotherapy|May 3, 2023
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm-related infectionsNikki N Tran, Taylor Morrisette, Sarah C J Jorgensen, et al.
Open Forum Infectious Diseases|July 9, 2019
Long-Acting Lipoglycopeptides: "Lineless Antibiotics" for Serious Infections in Persons Who Use DrugsTaylor Morrisette, Matthew A Miller, Brian T Montague, et al.
Antibiotics (Basel, Switzerland)|September 28, 2024
Real-World Clinical Characteristics and Outcomes with Daptomycin Use in Pediatric Patients: A Retrospective Case SeriesHanna Persha, Stephen A Thacker, Krutika Mediwala Hornback, et al.
Infectious Diseases and Therapy|August 3, 2020
The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the HorseTaylor Morrisette, Thomas P Lodise, Marc H Scheetz, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2019
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infectionsTaylor Morrisette, Matthew A Miller, Brian T Montague, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 13, 2020
Ribavirin and cellular ribavirin-triphosphate concentrations in blood and bronchoalveolar lavage fluid in two lung transplant patients with respiratory syncytial virusScott W Mueller, Tyree H Kiser, Taylor Morrisette, et al.
Pharmacotherapy|April 3, 2020
Advantages of Outpatient Treatment with Long-Acting Lipoglycopeptides for Serious Gram-Positive Infections: A ReviewMartin Krsak, Taylor Morrisette, Matthew Miller, et al.
Infectious Diseases and Therapy|December 20, 2025
The Cefazolin Inoculum Effect: An Underappreciated Factor in MSSA Treatment StrategiesPrakhar Srivastava, Elizabeth Singleton, Taylor Morrisette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2020
Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue InfectionsSara Alosaimy, Kyle P Murray, Evan J Zasowski, et al.
Journal of Applied Microbiology|June 2, 2022
Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testingDana J Holger, Katherine L Lev, Razieh Kebriaei, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
Pharmacotherapy|May 3, 2023
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm-related infectionsNikki N Tran, Taylor Morrisette, Sarah C J Jorgensen, et al.
Open Forum Infectious Diseases|July 9, 2019
Long-Acting Lipoglycopeptides: "Lineless Antibiotics" for Serious Infections in Persons Who Use DrugsTaylor Morrisette, Matthew A Miller, Brian T Montague, et al.
Antibiotics (Basel, Switzerland)|September 28, 2024
Real-World Clinical Characteristics and Outcomes with Daptomycin Use in Pediatric Patients: A Retrospective Case SeriesHanna Persha, Stephen A Thacker, Krutika Mediwala Hornback, et al.
Infectious Diseases and Therapy|August 3, 2020
The Pharmacokinetic and Pharmacodynamic Properties of Hydroxychloroquine and Dose Selection for COVID-19: Putting the Cart Before the HorseTaylor Morrisette, Thomas P Lodise, Marc H Scheetz, et al.
The Journal of Antimicrobial Chemotherapy|July 20, 2019
On- and off-label utilization of dalbavancin and oritavancin for Gram-positive infectionsTaylor Morrisette, Matthew A Miller, Brian T Montague, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|September 13, 2020
Ribavirin and cellular ribavirin-triphosphate concentrations in blood and bronchoalveolar lavage fluid in two lung transplant patients with respiratory syncytial virusScott W Mueller, Tyree H Kiser, Taylor Morrisette, et al.
Pharmacotherapy|April 3, 2020
Advantages of Outpatient Treatment with Long-Acting Lipoglycopeptides for Serious Gram-Positive Infections: A ReviewMartin Krsak, Taylor Morrisette, Matthew Miller, et al.
Infectious Diseases and Therapy|December 20, 2025
The Cefazolin Inoculum Effect: An Underappreciated Factor in MSSA Treatment StrategiesPrakhar Srivastava, Elizabeth Singleton, Taylor Morrisette, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 28, 2020
Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue InfectionsSara Alosaimy, Kyle P Murray, Evan J Zasowski, et al.
Journal of Applied Microbiology|June 2, 2022
Bacteriophage-antibiotic combination therapy for multidrug-resistant Pseudomonas aeruginosa: In vitro synergy testingDana J Holger, Katherine L Lev, Razieh Kebriaei, et al.
Pageof 8